IL224381B - Application of b-functionalized dihydroxy-chlorins for pdt - Google Patents

Application of b-functionalized dihydroxy-chlorins for pdt

Info

Publication number
IL224381B
IL224381B IL224381A IL22438113A IL224381B IL 224381 B IL224381 B IL 224381B IL 224381 A IL224381 A IL 224381A IL 22438113 A IL22438113 A IL 22438113A IL 224381 B IL224381 B IL 224381B
Authority
IL
Israel
Prior art keywords
chlorins
pdt
application
functionalized
dihydroxy
Prior art date
Application number
IL224381A
Other languages
English (en)
Hebrew (he)
Original Assignee
Biolitec Unternehmensbeteiligungs Ii Ag
Biolitec Pharma Marketing Ltd
Ceram Gmbh
Ceramoptic Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolitec Unternehmensbeteiligungs Ii Ag, Biolitec Pharma Marketing Ltd, Ceram Gmbh, Ceramoptic Ind Inc filed Critical Biolitec Unternehmensbeteiligungs Ii Ag
Publication of IL224381B publication Critical patent/IL224381B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL224381A 2010-07-22 2013-01-23 Application of b-functionalized dihydroxy-chlorins for pdt IL224381B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36670710P 2010-07-22 2010-07-22
PCT/US2011/047576 WO2012012809A2 (en) 2010-07-22 2011-08-12 APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT

Publications (1)

Publication Number Publication Date
IL224381B true IL224381B (en) 2018-03-29

Family

ID=45497505

Family Applications (1)

Application Number Title Priority Date Filing Date
IL224381A IL224381B (en) 2010-07-22 2013-01-23 Application of b-functionalized dihydroxy-chlorins for pdt

Country Status (8)

Country Link
EP (1) EP2870159B1 (enExample)
JP (1) JP2013532664A (enExample)
CN (1) CN103097390B (enExample)
BR (1) BR112013001576A2 (enExample)
IL (1) IL224381B (enExample)
MX (1) MX353394B (enExample)
PL (1) PL2870159T3 (enExample)
WO (1) WO2012012809A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103096887B (zh) * 2010-07-22 2017-12-29 拜欧利泰克投资二代公司 用于抗微生物光动力疗法的糖取代的二羟基‑二氢卟酚和β‑官能化二氢卟酚
WO2013015774A1 (en) 2011-07-22 2013-01-31 Biolitec Pharma Marketing Ltd Glyco-substituted dihydroxy-chlorins and b-functionalized chlorins for anti-microbial photodynamic therapy
CN103995045A (zh) * 2014-05-29 2014-08-20 武汉矽感科技有限公司 离子迁移谱仪用于检测乐果和马拉硫磷残留的用途及方法
EP3292129B1 (en) * 2015-05-07 2019-03-27 Luzitin S.A. Low molecular weight halogenated porphyrine carboxamide chlorin and bacteriochlorin derivatives for use in photodynamic therapy for treating cancer
US9722103B2 (en) 2015-06-26 2017-08-01 Sunpower Corporation Thermal compression bonding approaches for foil-based metallization of solar cells
CN104940950B (zh) * 2015-07-09 2017-11-28 武汉大学 一种肿瘤靶向多肽光敏剂键合物
CN111196819B (zh) * 2018-11-16 2023-03-28 中国科学院上海药物研究所 一类d-a-d型苯并吡嗪类化合物及制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
FR2877943B1 (fr) * 2004-11-16 2008-09-05 Univ De Coimbra Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique
US9315510B2 (en) * 2008-09-18 2016-04-19 Biolitec Pharma Marketing Ltd Method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT
JP6041360B2 (ja) * 2011-07-22 2016-12-07 バイオリテック ウンターネーメンスベタイリグンクス ツヴァイ アクツィエンゲゼルシャフト 抗菌性光線力学療法のための、糖−置換ジヒドロキシ−クロリン及びβ−官能化クロリン

Also Published As

Publication number Publication date
PL2870159T3 (pl) 2018-01-31
CN103097390A (zh) 2013-05-08
MX2013000877A (es) 2013-07-03
CN103097390B (zh) 2017-03-08
JP2013532664A (ja) 2013-08-19
EP2870159B1 (en) 2017-06-28
MX353394B (es) 2018-01-11
EP2870159A4 (en) 2015-08-12
EP2870159A2 (en) 2015-05-13
WO2012012809A2 (en) 2012-01-26
WO2012012809A3 (en) 2012-05-18
BR112013001576A2 (pt) 2016-07-19

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
GB201003274D0 (en) Methods of connecting
ZA201304280B (en) Treatment of jak2-mediated conditions
GB2496805B (en) Compounds for photodynamic therapy
ZA201206456B (en) Uses of dgati inhibitors
ZA201303813B (en) Methods of treatment using lipid compounds
IL256026B (en) Treatment methods
IL224381B (en) Application of b-functionalized dihydroxy-chlorins for pdt
IL222474A0 (en) Method of synthesis
SI2407155T1 (sl) Preparati na osnovi inekalcitola
IL223926A0 (en) Synthesis of cyclopentaquinazolines
GB201005394D0 (en) Therapy
GB201016864D0 (en) Therapeutic methods
HU1000688D0 (en) Use of trifluoro-phal
AU2010900699A0 (en) Therapeutic Uses of SLIRP
TWM390349U (en) Structure of door-in-door
TWM386865U (en) Residue-filtering structure of juice-extractor
GB201000771D0 (en) Compound for therapy
AU2011900644A0 (en) Therapeutic Uses of SLIRP
GB201019938D0 (en) Determination of therapeutic agents
GB201009614D0 (en) Therapeutic use of compounds
TWM400763U (en) Improved structure of cold-accumulating cravats
TWM388315U (en) Improved structure of hemoclip
AU2010901837A0 (en) Methods of treatment
TWM390860U (en) Structure of granulator

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed